Clinical Trial Update: Effect of CoQ10 on the Outcome of MAFLD Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of Coenzyme Q10 on outcomes in patients with metabolic-associated fatty liver disease/non-alcoholic fatty liver dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic-associated Fatty Liver Disease
• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: Ain Shams University | Conditions: Fatty Liver, NAFLD | Phase 2 | Status: RECRUITING